Shue Youe Kong 4
4 · OPTIMER PHARMACEUTICALS INC · Filed Nov 16, 2010
Insider Transaction Report
Form 4
Shue Youe Kong
VP, clinical Development
Transactions
- Other
Common stock
2010-11-15$7.71/sh+1,453$11,202→ 91,560 total
Footnotes (1)
- [F1]Acquired under the Company's employee stock purchase plan on November 15, 2010.